MedPath
FDA Approval

IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 20, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ipratropium(0.5 mg in 3 mL)
Salbutamol(2.5 mg in 3 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE

Product Details

NDC Product Code
76204-600
Application Number
ANDA202496
Marketing Category
ANDA (C73584)
Route of Administration
RESPIRATORY (INHALATION)
Effective Date
December 20, 2023
Code: J697UZ2A9JClass: ACTIRQuantity: 0.5 mg in 3 mL
Code: 021SEF3731Class: ACTIMQuantity: 2.5 mg in 3 mL
© Copyright 2025. All Rights Reserved by MedPath